Cargando…
Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19
PROBLEM: As of 2020, less than 5% of physicians in the United States have a drug enforcement administration-X waiver to prescribe buprenorphine. The coronavirus-2019 pandemic restricted in-person gatherings, including traditional drug enforcement administration-X waiver courses. As a result, in-pers...
Autores principales: | Martin, Alister, Raber, Joshua P., Shayer, Desiree, Lai, Deborah, Goodcoff, Adam, Kannikal, Jasmine, Raja, Ali S., He, Shuhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529309/ https://www.ncbi.nlm.nih.gov/pubmed/34691756 http://dx.doi.org/10.1177/20552076211048985 |
Ejemplares similares
-
189 Get Waivered Remote: A Nationwide, Remote, and Interactive Educational Conference Designed in Response to COVID-19
por: Shayer, D., et al.
Publicado: (2020) -
The End of the X-Waiver: Not a Moment Too Soon!
por: Pergolizzi, Joseph, et al.
Publicado: (2021) -
Home and Community-Based Services Waivers
por: Duckett, Mary Jean, et al.
Publicado: (2000) -
Buprenorphine Waiver Attitudes Among Primary Care
Providers
por: Lai, Benjamin, et al.
Publicado: (2022) -
State Health Reform and the Role of 1115 Waivers
por: Riley, Trish
Publicado: (1995)